First it was Marie Claire magazine with their “Stiletto Stoners”, followed by a sympathetic follow-up on the NBC Today Show. Now Elle Magazine prints 2,758 words from another Stiletto Stoner who has discovered that cannabis is a superior medication for her generalized anxiety disorder than the Zoloft and Paxil her doctors had recommended.

(Elle Magazine) A thimbleful is all it takes. After a day’s work, I pinch off a small amount of marijuana and put it in a steel-tooth grinder. The flowers, covered in tiny white diamonds of THC, release a piney scent when crushed. I turn on the TV, and instead of taking a glass of wine with my evening news, I take out my vaporizer and set it on the coffee table.

One could say I diagnosed myself in high school, when I recognized my symptoms in a psychology textbook. Finally, I had “generalized anxiety disorder” to describe the dread I felt of some future event that was overtaking my present. I usually sensed the panic attacks first in my chest. Then my vision would start to go to static, and my body would crumple to the floor. There I’d ride it out until the adrenaline ran its course.

Soon after I started to suffer several of these episodes a day (and so often that fear of another one kept me indoors), I sought out a psychiatrist. I told her about the times I’d be driving and convince myself that I was about to spin off the road—the looping, invented terrors. A little talk therapy and a prescription later, I discovered that Zoloft only exacerbated my panic and depression. I stopped taking the little white pills and cut out caffeine instead; I exercised and practiced meditation. For years I abstained from medication, and aside from the occasional pot smoking with friends, I swore off drugs entirely.

About four years ago, another psychiatrist put me on lithium for what he described as my “Paxil-induced hypomania.” When it made me violently sick, I decided I needed to replace pills altogether and turn to a regimen that relied on what was, to me, the only proven drug. I headed down to the five-block stretch of marijuana advocacy groups known as “Oaksterdam.” There, I explained to an understanding doctor, wearing Lennon glasses and cargo shorts, that marijuana eased the symptoms of what studies showed and I knew to be a genetic disorder. (My two younger brothers have been diagnosed as bipolar, and my grandmother suffered from anxiety and depression.)

The writer continues by explaining how she is able to keep her job and be productive thanks to marijuana, and that her friends that use marijuana are all successful productive people she’s proud to know. She worries about the legal complexities, especially how the California Ragingwire decision still allows employers to fire people for their medical use.

From a media standpoint, I believe when you’re having women speak favorably of marijuana in Marie Claire, the Today Show, and Elle Magazine, you’re winning the hearts and minds.

In the recent wake of Stiletto Stoners, comes part two of Marie Myung-Ok Lee’s brave and revealing account of how medical cannabis helps her autistic 9-year old son. Read part one here.

Marie and her son J. live in Rhode Island, a state where the legislators have both the chutzpah and foresight to have overridden two vetoes from the Governor (and pressure from the federal government anti-drug officials and law enforcement) in the last 24 moths to create the legal and public health framework necessary for Ms. Young and her physician to be able to effectively and safely treat J. with cannabis-oil cookies.

This essay, and others by women for whom cannabis plays an important role in their lives, are becoming more and more common in the mainstream media to the point where a forum or advisory body about ‘women and cannabis’ is certainly warranted.

NORML wants to convene such a confab in 2010 and seeks input from cannabis consumers and the general public about what kind of topics should be discussed and who should the speakers be. Please send your suggestions and feedback to: conference@norml.org

This essay was originally published at Doublex.com.

Check it out on http://live.norml.org – Rick Steves coming up soon, plus discussions from the founder of Oaksterdam, Richard Lee; Dr. Harry Levine on race and marijuana arrests; and California NORML’s Dale Gieringer on the current legal landscape there.

Three hours of live audio from Thursday’s panels at NORML National Conference are now available at our archive of NORML SHOW LIVE. You’ll hear NORML Deputy Director Paul Armentano on the science and medicine of marijuana, followed by a panel on patients, caregivers, and small patient collectives moderated by William Panzer, one of the co-authors of Prop 215.

Chris Goldstein and Russ Belville are collecting all the photos, audio, and video from the conference for upload as the day continues.

NORML’s new talk radio program, NORML SHOW LIVE, will be streaming for three days at the 2009 NORML National Conference, “Yes We Cannabis”, live from the Grand Hyatt Hotel in San Francisco. These special three-hour episodes will be available at live.norml.org at the following special times and archived for download later just fifteen minutes after broadcast:

1. Thursday, September 24
   11:00am – 2:00pm Pacific Time
2. Friday, September 25
   11:00am – 2:00pm Pacific Time
3. Saturday, September 26
   3:00pm – 6:00pm Pacific Time

The show will be hosted by “Radical” Russ Belville, but with very limited commercial interruption and the occasional narration.  After the shows broadcast remotely in the difficult wireless environment of Portland’s Kelley Point Park and the noisy backstage of the Boston Freedom Rally, Russ is excited to present an indoor event that will take its audio directly from the conference PA system.

Full Story

NORML is proud to confirm that Dr. Lester Grinspoon will be delivering the luncheon remarks (via skype) at the 2009 National Conference in San Francisco, CA.

Dr. Grinspoon is Associate Professor Emeritus of Psychiatry at Harvard Medical School, and served for 40 years as Senior Psychiatrist at the Massachusetts Mental Health Center in Boston. A Fellow of both the American Association for the Advancement of Science and the American Psychiatric Association, he was the founding editor of both the Annual Review of Psychiatry and the Harvard Mental Health Letter.

He is the author or co-author of over 160 journal articles, including his 1995 commentary in the Journal of the American Medical Association entitled “Marihuana as Medicine: A Plea for Reconsideration.” His first book, Marihuana Reconsidered, originally published in 1971 by Harvard University Press, was recently republished as a classic. His latest book, Marihuana, the Forbidden Medicine, co-authored with James B. Bakalar, was published by Yale University Press in 1993 (revised and expanded edition, 1997) and has now been translated into ten languages. Dr. Grinspoon was also a reviewer of the 1999 Institute of Medicine report, “Marijuana and Medicine: Assessing the Science Base.”

In 1990 Dr. Grinspoon received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship and Writing from the Drug Policy Foundation (now Alliance) in Washington, DC. He presently serves on NORML’s Advisory Board and maintains www.marijuana-uses.com, which chronicles real life stories of people who have had positive “non-medical” experiences with marijuana.

“When I first began to study marijuana in 1967, I naïvely believed that its only use was as a recreational drug,” says Grinspoon. “I soon came to understand that it also had a second important utility, as a medicine, and I published (along with James B. Bakalar) Marijuana, the Forbidden Medicine.  Just as penicillin, after its discovery as an antibiotic in 1941, was soon hailed as a wonder drug because of its limited toxicity, its versatility in treating a number of different kinds of symptoms and syndromes, and its limited cost, we believe that marijuana, for the same three reasons, will eventually be hailed as a wonder medicine. Over the last decade and a half I have come to believe that there is a third category of marijuana use –enhancement.”

Lester Grinspoon says, “Yes we cannabis” and so should you! Register for NORML’s 38th annual conference, taking place September 24-26 at the Grand Hyatt Hotel in downtown San Francisco. For registration information, please visit: http://www.norml.org/conference.

More about Dr. Lester Grinspoon:

Dr. Lester Grinspoon’s Marijuana Uses webpage: http://marijuana-uses.com/index.html

JAMA: Marihuana as Medicine: A Plea for Reconsideration: http://www.csdp.org/kz/tlcjama.html

Boston Globe: Marijuana as Wonder Drug: http://www.rxmarijuana.com/wonder_drug.htm

Recently, the Substance Abuse and Mental Health Services Administration (SAMHSA) released a state-by-state drug use report that is both useful and informative. These government reports, like others regarding drug use, are based on surveys and the willingness of respondents to be truthful about their illicit drug use.

According to SAMHSA, what states had the highest and lowest marijuana rates of cannabis use? Rhode Island (16.2%) and Utah (7.17%) respectively.

The New York Times‘ Economix blog created some helpful interactive mapping to illustrate the SAMSHA  data.

[Editor's Note: This interesting and informative exchange of ideas, provided by experts on cannabis regarding the future of America's cannabis policy, was originally published July 19 on the 'Open for Debate' blog found at the New York Times' webpage.]

If Marijuana Is Legal, Will Addiction Rise?

By The Editors
July 19, 2009, 7:00 pm

A New York Times article on Sunday discussed the debate over whether more and more potent types of cannabis affect the levels of addiction to the drug. This particular issue has become part of the larger debate over whether marijuana should be legalized or decriminalized.

Antidrug activists say that if the drug is legalized, more people will use it and addiction levels, made worse by the increased potency, will rise too. Legalization advocates note that pot addiction is not nearly as destructive as, say, abuse of alcohol. What would be the effect of legalization or decriminalization on marijuana abuse and addiction?

*Roger Roffman, professor of social work

*Wayne Hall, professor of public health policy

*Mark A.R. Kleiman, professor of public policy and author

*Peter Reuter, University of Maryland professor

*Norm Stamper, former Seattle police chief

Full Story

The Substance Abuse and Mental Health Services Administration, or SAMHSA, is the Federal Government’s lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States. They have released the results of their 2007 Treatment Episode Data Set, or TEDS, showing the National Admissions to Substance Abuse Treatment Services. Let’s take a look at the statistics for marijuana, shall we?

50% increase in marijuana treatment admissions in one decade

In 1997, about 200,000 people checked into treatment for marijuana. By 2005, that number has risen to over 300,000 people, though it has tapered off a bit these last couple of years. By any account, this is a huge rise in the number of people seeking rehab for marijuana in just a decade. It would seem like the powerful new “Not Your Father’s Woodstock Weed” has given rise to a 50% increase in reefer addicts!

Only 15% of marijuana "addicts" admit themselves to treatment

However, when you look behind the numbers, you find that this increase has more to do with the rapid increase of drug courts in the late ’90s, early ’00s. By far, most of the people who are in treatment for marijuana are forced there! 57% are forced into treatment by the criminal justice system, while only 15% admitted themselves to treatment. For comparison’s sake, over all drugs combined, 1/3rd of all admissions are self-admissions, marijuana is the drug with the lowest self-admission rates (lower than meth) and highest criminal justice-admission rates (higher than meth), and for alcohol, self-admission is around 29% and criminal justice (including DUI) admissions are only 42.5%.

Full Story

Each week, more states are moving forward to reduce or eliminate criminal penalties for marijuana offenses. If you have not yet gotten active in your state, now is most definitely the time to start. Here’s this week’s latest summary of how you can get involved!

Illinois: On Wednesday, March 4, both chambers of the Illinois legislature will hold hearings to discuss the need to legalize the medical use of cannabis under state law. Members of the House Human Services Committee will hear testimony in favor of House Bill 2514 at 8am in the Stratton Building, Room D-1. Later that afternoon, members of the Senate Public Health Committee are also scheduled to hear testimony in favor of Senate Bill 1381. You can contact your elected officials in support of these measures by going here, or by getting in touch with the good folks at Illinois NORML.

UPDATE!!! UPDATE!!! House Bill 2514 was voted out of Committee on a 4 to 3 vote. This marks the first time a House Committee has approved legislation regarding the medical use of cannabis. For more information, please visit here.

Maine: Members of the the Joint Standing Committee on Criminal Justice and Public Safety Committee heard testimony last week in favor of LD 250, which seeks to amend state law so that the possession of up to four ounces of marijuana would be classified as a civil violation. Predictably, local law enforcement are opposing this effort. That is why Maine legislators need to hear from you. Contact members of legislature here, and tell them to vote ‘yes’ on LD 250.

Texas: Anyone who follows the marijuana law reform issue knows that change in the Lone Star State is long overdue. That’s why it is important that members of the Texas cannabis community get behind House Bill 902, which would reduce minor marijuana possession penalties to a fine-only offense. Over 60,000 Texans are arrested for pot possession violations annually. Half of these defendants are under 25 years of age. It makes no sense to saddle these young people with a criminal arrest record or to put them in jail. Tell your representatives to support HB 902 by going here, and by becoming involved with Texas NORML.

Rhode Island: This Wednesday, March 4, both chambers of the legislature will hear testimony in favor of legislation to mandate the Department of Health to establish rules governing the licensing of non-profit compassion centers “to acquire, possess, cultivate, manufacture, deliver, transfer, transport, supply, or dispense marijuana, or related supplies and educational materials, to registered qualifying patients.” To learn more about this effort, or to attend these hearings, please visit our allies at the Rhode Island Patient Advocacy Coalition.

New Hampshire: Next Monday, March 9, members of the House Health, Human Services & Elderly Affairs Committee will hear testimony at 10am in favor of House Bill 648, which seeks to legalize the use of medical cannabis is New Hampshire. Two years ago the House narrowly rejected (186-177) a similar bill, so it vital that you contact your House members and urge them to support HB 648. You can write them here. And if you wish to attend next week’s hearing, our allies NH Compassion have all the information you need here.

To learn about additional pending legislation in Alabama, California, Connecticut, Minnesota, Missouri, Montana, New Jersey, Oregon, Tennessee, and Washington, please visit NORML’s Legislative Action Alerts page here.